1996
DOI: 10.1001/jama.1996.03530430027034
|View full text |Cite
|
Sign up to set email alerts
|

Perinatal HIV Infection and the Effect of Zidovudine Therapy on Transmission in Rural and Urban Counties

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
42
1

Year Published

1996
1996
2004
2004

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 131 publications
(46 citation statements)
references
References 15 publications
3
42
1
Order By: Relevance
“…31 To determine the range of acceptance rates for the sensitivity analysis, we used acceptance rates from women who came for services to the Chicago Department of Public Health Sexually Transmitted Disease Clinics and were offered HIV testing 32 and acceptance rates from other published reports in the medical literature. [33][34][35][36][37] The acceptance of AZT by pregnant women after they are told their HIV status is based on estimates from published studies and results obtained from the University of Illinois Women's Health Clinic 14,38,39 (M. Vajaranant, personal communication, August 1998).…”
Section: Probability Estimatesmentioning
confidence: 99%
“…31 To determine the range of acceptance rates for the sensitivity analysis, we used acceptance rates from women who came for services to the Chicago Department of Public Health Sexually Transmitted Disease Clinics and were offered HIV testing 32 and acceptance rates from other published reports in the medical literature. [33][34][35][36][37] The acceptance of AZT by pregnant women after they are told their HIV status is based on estimates from published studies and results obtained from the University of Illinois Women's Health Clinic 14,38,39 (M. Vajaranant, personal communication, August 1998).…”
Section: Probability Estimatesmentioning
confidence: 99%
“…The study provided proof of the principle that anti-retroviral drug prophylaxis can reduce mother-to-child HIV transmission. Uptake of the regimen in clinical practice in the U.S. and Europe has been remarkable, and has been coincident with dramatic declines in new HIV infections among children (Fiscus et al, 1996;Centres for Disease Control and Prevention, 1993Lindegren et al, 1999).…”
Section: Benefits Of Anti-retroviral Drugsmentioning
confidence: 99%
“…The regimen followed by American Control Trial Group (ATCG 076) using zidovudine monotherapy aims to intervene at all possible stages of transmission Le, antenatal, intrapartum, postpartum & neonatal. Zidovudine has consistently resulted in reductions of 65-75% in infant infections with no immediate serious consequences to the mother, infant, or child development during the first two years of life [19]. Zidovudine significantly decreases the likelihood of vertical tranmission at all observed levels of maternal HIY viral load [20].…”
Section: Perinatal Transmissionmentioning
confidence: 99%